Public Meeting – Reauthorization of MDUFA for 2023-2027

The U.S. Food and Drug Administration (FDA) is announcing a public meeting entitled Reauthorization of the Medical Device User Fee Program (MDUFA).

The purpose of this public meeting is to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2023 through 2027.

Meeting Date: Tuesday, April 7, 2020
Location: The FDA’s White Oak Campus in Silver Spring, MD. The meeting will also be webcast.
Registration Deadline: Thursday, March 26, 2020 at 4:00 p.m.

Learn More and Register

Important Deadlines

March 23, 2020: Request special accommodations for the meeting.
March 26, 2020: Register to attend the meeting.
March 26, 2020: Request to make oral presentations during the public comment session or a specific session.
May 6, 2020: Submit written comments to the docket (FDA-2020-N-0907).